Alternative splicing of human metabotropic glutamate receptor 3.
about
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsPositive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatmentClustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorderMetabotropic glutamate receptors: from the workbench to the bedside.Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia.Characterization of a truncated metabotropic glutamate receptor in a primitive metazoan, the parasitic flatworm Schistosoma mansoniAnalysis of whole genome biomarker expression in blood and brainGenetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brainsEpistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain functionRole of glutamate in schizophrenia: integrating excitatory avenues of research.Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.Group II metabotropic glutamate receptors and schizophrenia.Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms.Metabotropic glutamate receptors: physiology, pharmacology, and disease.Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indicationsMeta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk.Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout miceExpression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding.The contribution of alternative splicing to genetic risk for psychiatric disorders.
P2860
Q26744729-DCF31829-8FD8-47E9-92BE-A1B3B0B433A0Q26852047-40ED01ED-D5F4-43D7-BE25-8BE5DCAEAA24Q28477965-0A127E42-6780-4D38-8328-C2E2E4651302Q30448778-87FFFA7E-455A-4FE9-AAE0-005B04ECFCFCQ33295367-01860A13-3C81-43F4-A3A9-C185C17FA1DCQ34070596-5F32495D-C237-4BDE-9D79-CE57091A20C1Q34994239-0B300354-837B-4FF2-82F7-676635DB63E0Q35153945-4623D9C3-18F8-44AC-862D-1A92A1ADB087Q35894585-F2F12F38-846A-49DB-9505-B099C4ED8C05Q37256709-21611752-477C-46BF-9BA1-B737D66FA954Q37358875-69887F6D-C611-4F10-95F0-511CEF293873Q37473779-673190A1-27C2-4273-9470-46989D36A3B4Q37486473-6FB41821-C203-45CE-B502-6AD1302368A5Q37563065-589F2134-7F73-4B91-B865-85F1F4526C10Q37670222-12AA360A-0655-42DE-A69F-960969DE213BQ38209092-B23E0936-1459-406C-AB71-224ABDBBE4E0Q41687534-6CED8816-68F9-4CC3-AC47-3D011A8CB140Q41779206-1AE2B3F5-B5F3-4E87-8157-1521A405F4FEQ46767433-206B30EE-48A6-4F6E-A60D-A1AC7F0FADF5Q47138421-377061FB-529B-427A-A8FA-7BD62AE6C027Q47593150-D9F74AE5-45B4-431A-B157-3E40029EA2A9
P2860
Alternative splicing of human metabotropic glutamate receptor 3.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Alternative splicing of human metabotropic glutamate receptor 3.
@en
type
label
Alternative splicing of human metabotropic glutamate receptor 3.
@en
prefLabel
Alternative splicing of human metabotropic glutamate receptor 3.
@en
P2093
P2860
P1476
Alternative splicing of human metabotropic glutamate receptor 3.
@en
P2093
Barbara K Lipska
Guhan Nagappan
Leah J Sartorius
Paul J Harrison
Renee Ren-Patterson
Yoshitatsu Sei
P2860
P304
P356
10.1111/J.1471-4159.2005.03609.X
P407
P577
2006-01-17T00:00:00Z